Direxion Daily S&P Biotech Bear 1X ETF (LABS) Analysis
Esta página foi traduzida automaticamente do original em inglês por IA; a versão em inglês é a que prevalece. Ler a versão em inglês
Apenas para fins informativos. Não é um conselho financeiro.
Direxion Daily S&P Biotech Bear 1X ETF (LABS) ETF — Price, Holdings & Analysis
Visão Geral do ETF
Métricas de Risco
- iShares Morningstar Small-Cap Growth ETF (JKK) — 0.06% expense ratio
- ARK Innovation ETF (ARKK) — 0.75% expense ratio
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
- WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
- Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
- Direxion MSCI Developed Over Emerging Markets ETF (RWDE) (Equity) — 0.53% expense ratio
- Direxion Russell Small Over Large Cap ETF (RWSL) (Equity) — 0.59% expense ratio
- Direxion Daily Global Clean Energy Bull 2X Shares (KLNE) (Equity) — 1.33% expense ratio
- Direxion Daily Uranium Industry Bull 2X ETF (URAA) (Equity) — 1.46% expense ratio
- Direxion Daily XOM Bull 2X ETF (XOMX) (Equity) — 2.36% expense ratio
- Direxion Daily AMD Bull 2X ETF (AMUU) (Equity) — 1.16% expense ratio
Perguntas e Respostas
How long has LABS been around?
Direxion Daily S&P Biotech Bear 1X ETF was launched in 2015, making it 11 years old. With over a decade of history, it has navigated various market conditions.
Is LABS a good investment?
Direxion Daily S&P Biotech Bear 1X ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.
Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.
Aviso Legal: Este conteúdo tem fins informativos apenas e não constitui aconselhamento de investimento. Sempre faça sua própria pesquisa e consulte um consultor financeiro.
Dados fornecidos apenas para fins informativos.
Escrito por uma máquina, sem revisão página a página. A supervisão editorial é sistémica: verificam-se as regras e as fontes, não cada página.